Norrett Kevin
Insider CIK 1819690 · CDXS Chief Operating Officer · SRRA Chief Business Officer · SLNO Chief Business Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SLNO SOLENO THERAPEUTICS INC | D To issuer deriv | 2026-05-18 | 2026-05-18 | 64,286 | — | $0 | 0 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | D To issuer deriv | 2026-05-18 | 2026-05-18 | 4,000 | — | $0 | 0 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | D To issuer | 2026-05-18 | 2026-05-18 | 17,786 | — | $0 | 0 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | A Award deriv | 2026-01-21 | 2026-01-23 | 4,000 | — | $0 | 4,000 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | A Award | 2026-01-21 | 2026-01-23 | 3,500 | — | $0 | 17,786 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | M Exercise deriv | 2025-11-17 | 2025-11-19 | 64,286 | — | $0 | 64,286 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | A Award | 2025-11-17 | 2025-11-19 | 14,286 | — | $0 | 14,286 | SEC↗ |
| CDXS CODEXIS, INC. | A Award deriv | 2025-02-05 | 2025-02-07 | 161,250 | — | $0 | 161,250 | SEC↗ |
| CDXS CODEXIS, INC. | A Award | 2025-02-05 | 2025-02-07 | 26,875 | — | $0 | 177,327 | SEC↗ |
| CDXS CODEXIS, INC. | A Award deriv | 2024-01-01 | 2024-01-02 | 314,125 | — | $0 | 314,125 | SEC↗ |
| CDXS CODEXIS, INC. | A Award | 2024-01-01 | 2024-01-02 | 52,350 | — | $0 | 150,452 | SEC↗ |
| CDXS CODEXIS, INC. | P Buy | 2023-09-11 | 2023-09-12 | 9,000 | $1.72 | $15.5K | 98,102 | SEC↗ |
| CDXS CODEXIS, INC. | S Sale | 2023-03-08 | 2023-03-09 | 8,258 | $4.56 | $37.7K | 89,102 | SEC↗ |
| CDXS CODEXIS, INC. | S Sale | 2023-03-07 | 2023-03-09 | 8,596 | $4.60 | $39.5K | 97,360 | SEC↗ |
| CDXS CODEXIS, INC. | A Award deriv | 2023-02-21 | 2023-02-21 | 67,500 | — | $0 | 67,500 | SEC↗ |
| CDXS CODEXIS, INC. | A Award | 2023-02-21 | 2023-02-21 | 22,500 | — | $0 | 22,500 | SEC↗ |
| CDXS CODEXIS, INC. | A Award | 2023-02-08 | 2023-03-09 | 83,456 | — | $0 | 105,956 | SEC↗ |
| CDXS CODEXIS, INC. | A Award deriv | 2022-10-03 | 2022-10-05 | 413,405 | — | $0 | 413,405 | SEC↗ |
| SRRA Sierra Oncology, Inc. | D To issuer deriv | 2022-07-01 | 2022-07-01 | 35,000 | — | $0 | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | D To issuer deriv | 2022-07-01 | 2022-07-01 | 11,700 | — | $0 | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | D To issuer deriv | 2022-07-01 | 2022-07-01 | 49,000 | — | $0 | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | D To issuer deriv | 2022-07-01 | 2022-07-01 | 100,000 | — | $0 | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | A Award deriv | 2022-06-17 | 2022-06-17 | 12,250 | — | $0 | 12,250 | SEC↗ |
| SRRA Sierra Oncology, Inc. | A Award deriv | 2022-03-14 | 2022-03-14 | 35,000 | — | $0 | 35,000 | SEC↗ |
| SRRA Sierra Oncology, Inc. | A Award deriv | 2022-01-28 | 2022-01-28 | 12,250 | — | $0 | 12,250 | SEC↗ |
| SRRA Sierra Oncology, Inc. | A Award deriv | 2021-03-15 | 2021-03-17 | 11,700 | — | $0 | 11,700 | SEC↗ |
| SRRA Sierra Oncology, Inc. | A Award deriv | 2020-08-10 | 2020-08-11 | 100,000 | — | $0 | 100,000 | SEC↗ |